Citryll is a startup based in the Netherlands, most recent round Series A, 3 tracked investors.
Based in the Netherlands, Citryll is a startup founded in 2023. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Citryll is a biotechnology company developing novel therapeutics for autoimmune and inflammatory diseases. Their lead program, CIT-001, targets citrullinated proteins to reduce inflammation and tissue damage.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.